Adult-onset Still's Disease
Welcome,         Profile    Billing    Logout  
 6 Companies   1 Product   1 Product   0 Mechanisms of Action   0 Trials   5 News 
  • ||||||||||  tadekinig alfa (IL-18BP) / AB2 Bio
    Trial completion, Enrollment change:  Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease (clinicaltrials.gov) -  Aug 30, 2016   
    P2,  N=23, Completed, 
    Active, not recruiting --> Completed | N=60 --> 23 Recruiting --> Completed | N=30 --> 23
  • ||||||||||  Arcalyst (rilonacept) / Regeneron, Kiniksa
    Trial completion:  Interleukin-1 Trap to Treat Autoinflammatory Diseases (clinicaltrials.gov) -  Mar 5, 2014   
    P2,  N=11, Completed, 
    Recruiting --> Completed | N=30 --> 23 Active, not recruiting --> Completed